BP1076 Vaccinia Virus (Lister Strain) Antikörper

See related secondary antibodies

Search for all "Vaccinia Virus"

1 ml / 530,00 €
Please visit the country specific website of OriGene Technologies or contact your local Distributor to buy this product.

Kurzübersicht

Rabbit anti Vaccinia Virus

BP1076

Produktbeschreibung für Vaccinia Virus

Rabbit anti Vaccinia Virus.
Properties: (Lister Strain)
Presentation: Purified
Product is tested for Enzyme Immunoassay, Paraffin Sections.

Produktdaten von Vaccinia Virus

Produkt-Kategorie Primärantikörper
Target-Kategorie
Menge 1 ml
Präsentation Purified
Anwendungen E, P
Klonalität Polyclonal
Wirt Rabbit
Shipping to Worldwide
PDF datasheet Datenblatt ansehen
Hersteller OriGene Technologies GmbH
Material safety datasheet MSDS for Polyclonal Antibodies (de)

Datenblatt-Auszug

Immunogen
Immunogen:
Lister Strain (mixture of virions and infected cell polypeptides)
Eigenschaften Lister Strain
Anwendung ELISA.
Immunohistochemistry (Protein K digestion is recommended with Formalin-Fixed Paraffin Embedded Sections).
Background Vaccinia virus is an Orthopoxvirus, containing double stranded DNA. Fusion protein plays an important role in the entry of enveloped virus into cells. As vaccinia virus has a wide host range, it is conceivable that certain cellular components that are ubiquitously expressed on the cell mediate virus infection. The study of the entry process, attachment, fusion and the proteins and receptors involved is complex. During vaccinia virus infection, the fusion process is attributed to the action of the 14KDa protein (A27L). The N terminus of this protein recognises heparan sulfate on the cell surface. It interacts with the negative charges of sulfates of glycosaminoglycans (GAGs). Therefore, antibodies that recognize this 14KDa protein are able to neutralize vaccinia virus infection and enable identification other viral and cellular proteins which participate in the vaccinia virus entry process.
Concentration 4-5 mg/ml (OD280 nm, E0.1% = 1.4)
Product Citations
Purchased from Acris:
  1. Teoh D, Johnson LA, Hanke T, McMichael AJ, Jackson DG. Blocking development of a CD8+ T cell response by targeting lymphatic recruitment of APC. J Immunol. 2009 Feb 15;182(4):2425-31. doi: 10.4049/jimmunol.0803661. PubMed PMID: 19201897.
  2. Miller L, Michel J, Vogt G, Döllinger J, Stern D, Piesker J, et al. Identification and characterization of a phage display-derived peptide for orthopoxvirus detection. Anal Bioanal Chem. 2014 Nov;406(29):7611-21. doi: 10.1007/s00216-014-8150-8. Epub 2014 Oct 14. PubMed PMID: 25311190.
General Readings
  1. Fedorko DP, Preuss JC, Fahle GA, Li L, Fischer SH, Hohman P, et al. Comparison of methods for detection of vaccinia virus in patient specimens. J Clin Microbiol. 2005 Sep;43(9):4602-6. PubMed PMID: 16145113. (Free PMC Article available)
Storage Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
Format
Purification:
Protein A Chromatography
Buffer System:
0.01M PBS, pH 7.2
Preservatives:
0.09% Sodium Azide
Stabilizers:
None
State:
Liquid purified Ig fraction (> 95% pure)
Purified
Specificity
Specificity:
Recognizes purified virions.
Does not cross-react with Parainfluenza (1-3), RSV, Adenovirus, Influenza A & B or HSV-1.
Does not react with uninfected cells.
Reactive with Lister, Wyeth, New York City and MVA strains of Vaccinia.

Accessory Products

  • LinkedIn